The main plot of these compounds is to stabilize the natural structure of the p53 DBD to resurrect its DNA binding ability and trans-activation of p53 target genes such as CDKN1A in order to induce cell death followed by obliterating the tumor [679]. The gene discussed is CDKN1A; the disease is neoplasm.